The US Food and Drug Administration iw widening the enquiry, seeking more data from clinical trials

  • FDA seeking raw safety data from clinical trials of similar vaccines developed by same scientists
  • The FDA does not necessarily indicate a safety problem associated with any of those vaccines

The market has been acting constructively on positive coronavirus vaccine stories. This is not a positive (in the short term at least) so should impact the opposite on risk.